Gene: GDAP1
Official Full Name: ganglioside induced differentiation associated protein 1provided by HGNC
Gene Summary: This gene encodes a member of the ganglioside-induced differentiation-associated protein family, which may play a role in a signal transduction pathway during neuronal development. Mutations in this gene have been associated with various forms of Charcot-Marie-Tooth Disease and neuropathy. Two transcript variants encoding different isoforms and a noncoding variant have been identified for this gene. [provided by RefSeq, Feb 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21814 | GDAP1 Knockout cell line (HeLa) | Human | GDAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO21815 | GDAP1 Knockout cell line (HCT 116) | Human | GDAP1 | 1:2~1:4 | Negative | Online Inquiry |
KO21816 | GDAP1 Knockout cell line (HEK293) | Human | GDAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO21817 | GDAP1 Knockout cell line (A549) | Human | GDAP1 | 1:3~1:4 | Negative | Online Inquiry |
GDAP1 Gene Knockout Cell Lines are specialized mammalian cell lines in which the GDAP1 gene has been effectively disrupted using advanced gene-editing techniques, such as CRISPR-Cas9. This gene encodes for the Ganglioside-Induced Differentiation-Associated Protein 1, which plays a critical role in mitochondrial dynamics and neuronal function. By studying these knockout cell lines, researchers can dissect the complex biological processes associated with GDAP1, particularly in the context of neurodegenerative diseases such as Charcot-Marie-Tooth disease.
The primary function of these knockout cell lines is to serve as a valuable tool for elucidating the downstream effects of GDAP1 deficiency on cellular metabolism, apoptosis, and mitochondrial morphology. Through the examination of altered pathways, scientists can gain insights into the etiology of diseases linked to GDAP1 mutations, opening avenues for therapeutic intervention. The ability to manipulate cellular systems in this manner is pivotal not only in academic research but also extends to drug development, genetic studies, and regenerative medicine.
What sets GDAP1 Gene Knockout Cell Lines apart from alternatives is their high specificity and efficiency in gene-editing, coupled with the robust data they provide in modeling human disease. These cell lines are also compatible with a variety of assays, including high-throughput screening, making them versatile for numerous experimental setups. This reliability facilitates reproducibility and accelerates discovery, inviting researchers to explore novel hypotheses with confidence.
For researchers and clinicians focused on neurobiology, these cell lines provide invaluable insights into mitochondrial dysfunction and its broader implications in human health. As the demand for precision tools in biomedical research grows, GDAP1 Gene Knockout Cell Lines represent an essential asset for advancing our understanding of genetic diseases.
Our company prides itself on its commitment to scientific innovation and provides a broad range of high-quality biological products tailored to meet the needs of modern research. With our expertise in genetic engineering and cell line development, we stand ready to support your research endeavors with products that advance knowledge and clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.